We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

605117:SSENingbo Deye Technology Co., Ltd. Class A Analysis

Data as of 2026-08-03 - not real-time

CN¥80.93

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Ningbo Deye trades below its discounted cash‑flow fair value, suggesting an undervalued entry point, while its price‑to‑earnings multiple sits under the industry average, adding a margin of safety. Strong cash reserves and a modest debt load underpin a healthy balance sheet, and the company’s payout ratio, though elevated, is supported by robust operating cash flow. Revenue growth remains exceptional, delivering a high return on equity and a solid dividend yield that enhances total return potential.
On the technical side, the 20‑day moving average remains under the 50‑day moving average, indicating a neutral to slightly bearish short‑term bias, yet the MACD histogram has turned positive, hinting at emerging momentum. RSI sits in the lower‑mid range, suggesting limited upside pressure but no immediate oversold condition. Volume has been tapering, and 30‑day price volatility is elevated, which tempers the bullish technical signal. Overall, the blend of attractive fundamentals and modest technical support points to a buy stance for medium to long horizons, while a cautious hold is prudent in the very short term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price approaching recent support level
  • RSI in the lower‑mid range limiting upside
  • decreasing volume indicating reduced short‑term participation

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • significant revenue growth and high ROE
  • valuation below DCF fair value and industry PE
  • strong cash generation supporting dividend sustainability

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • exposure to expanding renewable‑energy market
  • solid balance sheet with low leverage
  • consistent dividend yield enhancing total return

Key Metrics & Analysis

Financial Health

Revenue Growth73.80%
Profit Margin25.88%
P/E Ratio28.0
ROE33.40%
ROA13.31%
Debt/Equity22.99
P/B Ratio8.9
Op. Cash FlowCN¥5.3B
Free Cash FlowCN¥2.9B
Industry P/E30.9

Technical Analysis

TrendNeutral
RSI37.5
SupportCN¥77.48
ResistanceCN¥98.15
MA 20CN¥84.75
MA 50CN¥97.53
MA 200CN¥80.67
MACDBullish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

Fair ValueCN¥85.16
GradeUndervalued
TypeGrowth
Dividend Yield3.17%

Risk Assessment

Beta0.27
Volatility60.20%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.